Projects per year
Search results
-
Active
Targeting CD83 to reduce leukemia relapse and GVHD after allogeneic hematopoietic cell transplantation
Betts, B. (PI), Holtan, S. G. (CoI) & Linden, M. A. (CoI)
NIH NAT'L HEART, LUNG, AND BLOOD INSTITU
4/1/23 → 2/29/28
Project: Research project
-
PTCy + Sirolimus/VIC-1911 as GVHD prophylaxis in myeloablative PBSC transplantation
Grover, P. (PI) & Holtan, S. G. (Prior Principal Investigator)
8/20/21 → 8/31/26
Project: Research project
-
Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids for Treatment of Minnesota High-Risk Acute GVHD (aGVHD): A Phase I/II Study
Grover, P. (PI) & Holtan, S. G. (Prior Principal Investigator)
6/1/21 → 5/31/26
Project: Research project
-
AGAVE-201, A Phase 2, Open-label, Randomized, MulticenterStudy to Evaluate the Efficacy, Safety and Tolerability ofAxatilimab at 3 Different Doses in Patients with Recurrent orRefractory Active Chronic Graft Versus Host Disease who haveReceived at le
Holtan, S. G. (PI) & Arora, M. (Prior Principal Investigator)
11/1/20 → 10/31/25
Project: Research project
-
Single Arm Phase II Study of Ipilimumab and Nivolumab as
Kratzke, R. A. (PI), Domingo-Musibay, E. (Prior Principal Investigator) & Holtan, S. G. (Prior Principal Investigator)
BIG TEN CANCER RESEARCH CONSORTIUM, BRISTOL-MYERS SQUIBB COMPANY
12/1/17 → 3/31/25
Project: Research project